Telkonet Inc (fka TKO)

[lakingsphan0427]

VOLUME 325

Companies featured in this edition of the newsletter: ACCP, ACTC, CLXS, CVM, DOC, DVLY, GNBT, GSCR, HSOA, HYTM, MBND, MSHI, PBIO, PLKH, PLRS, SMGY, TAGS, TKO, USAT, VOIC

There were few places to hide last week, as investors aggressively sold off both leaders and laggards. Stocks suffered through their worst three-day period in five years, as the Dow lost 552 points for the week, trimming its annual gain to 4.6%. The Nasdaq fared no better, losing 182 points in absorbing its biggest weekly decline since September, 2001, and lowering it year-to-date return to 8.8%. The S&P dropped 55 points, equating to a yearly gain of 2.5%. The Russell 2000 lost 25 points, giving it a 1.9% deficit for the year.

Stocks were shattered last week on rising oil prices, the declining dollar and surging gold prices. Credit losses continued to dominate headlines as Citigroup announced it would take additional losses of $8 billion to $11 billion, Morgan Stanley reported its fourth-quarter profit would be reduced by $2.5 billion in write-downs and Wachovia indicated that in October alone it would take a $1.1 billion write-down. Recently stocks had risen on the anticipation that the third quarter was pretty much a kitchen-sink quarter. As we are seeing now, that is not the case. Additionally, any good economic news released last week was overshadowed by the dollar crisis raising concerns that foreign investors at some point may be less inclined to buy dollar-denominated securities. Oil prices edging closer to $100 a barrel only exacerbated the negative market reaction. Although General Motors reported a $39 billion charge was related to an accounting shift and not actual business prospects, such news still rattled investors. As consumers continue to feel the credit crunch along with higher food and gas prices, retailers could continue to release disappointing sales results, mirroring those released last week for the month of October. Is it any surprise that Consumer Confidence eroded in November to a reading of 64, significantly lower than October's reading of 80.6?

To be sure, stocks suffered considerable technical damage last week. Those looking for good news, would point to the fact that the August 16th low of 12,845 for the Dow has not been breached yet. Still, the Dow transportation average has already breached its August low. Several Wall Street firms, including Morgan Stanley, noted that big Nasdaq declines typically were followed by gains in the ensuing week or month. They pointed out how stocks began prior recessions with sharp corrections averaging 14.2%, but followed those with recovery rallies of 20.6%. In fact, last week's three-day rout caused double-digit percentage declines in Google, Apple, Microsoft, Research in Motion, Cisco, Oracle and many other blue-chip technology stocks, making a bounce at least a possibility.

What should investors look for this week? The Blackstone Group (NYSE: BX) and Tyson Foods (NYSE: TSN) are expected to report earnings Monday morning. Home Depot (NYSE: HD), and Wal-Mart Stores (NYSE: WMT) are expected to announce earnings before the opening bell on Tuesday. Steel-maker Arcelor Mittal (NYSE: MT), and Macy's Inc. (NYSE: M) will announce numbers before the opening bell on Wednesday, followed by Applied Materials (NASDAQ: AMAT) after the close of business. On Thursday, expect announcements from J.C. Penney (NYSE: JCP), Sears Holdings (NASDAQ: SHLD), Tyco International (NYSE: TYC), Kohl's Corp. (NYSE: KSS), and Starbucks Corp. (NASDAQ: SBUX).

The economic data expected next week begins with Pending Home Sales for September being reported at 10:00 a.m. Tuesday morning, followed by the Treasury Budget for October at 2:00 p.m. Retail Sales, PPI, and Core PPI for October will all be announced at 8:30 a.m. on Wednesday, followed by Business Inventories for September at 10:00 a.m., and weekly Crude Inventories at 10:30 a.m. CPI, and Core CPI for October will be released Thursday morning at 8:30, along with weekly Initial Jobless Claims, and the NY State Empire Index for November. At noon, look for commentary from the Philadelphia Fed. Net Foreign Purchases for September will be announced at 9:00 a.m. on Friday, with Industrial Production, and Capacity Utilization for October coming at 9:15 a.m.

Hythiam, Inc. (NASDAQ: HYTM), a provider of comprehensive behavioral health management services, sold approximately 9.6 million shares of its common stock to institutional investors for proceeds of roughly $46 million. The company also issued five-year warrants to purchase a total of about 2.4 million additional shares of its common stock at an exercise price of $5.75 per share. Proceeds of the offering are to be used for working capital and general corporate purposes. Notably, one of the company's directors led the financing. Shares have lost more than half of their value over the past month fueled by uncertainty about the results from Dr. Urschel's study of PROMETA (met the primary endpoint), Pierce County, Washington's decision to suspend funding for PROMETA (we believe it could reinstate funding this week according to commentary in a local Seattle newspaper) and the need to raise financing in a challenging market. Last week, HYTM also reported results for the third quarter ended September 30, 2007, which include the consolidated results from Comprehensive Care Corporation (CompCare). Hythiam recorded revenues of $12.0 million for the quarter, including a record $2.3 million in revenues from Hythiam's healthcare services business, a gain of over 110% from the year ago period. Revenues for nine months were $32.2 million, compared to $2.9 in 2006. Net loss for the quarter was ($0.31) per share, versus a loss of ($0.25) a year earlier. Net loss for nine months was ($0.83) compared to last year's loss of ($0.70). The company also reported that the total patients treated with the company's PROMETA treatment program grew 71% from a year earlier. Hythiam also reported that the Russian Patent Office has decided to grant Hythiam's patent relating to the treatment of cocaine dependency. The Russian Patent Office granted Hythiam a similar patent for the treatment of alcohol dependency in 2006. Drug use is rampant in Russia, with an estimated 6 million addicts, and up to 70,000 drug-related deaths every year. The patent protecting the intellectual property underlying the company's PROMETA Treatment Program for cocaine dependence and follows the granting of cocaine patents in other major markets over the past 12 months, including the U.S., Europe, Japan, and Korea, and has now received notifications of allowance or grants for inventions underlying its PROMETA protocols from over 28 countries. Shares ended the week at $4.00, down $1.97.

Earnings Preview: Pressure BioSciences, Inc. (NASDAQ: PBIO), a company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT), is scheduled to release third quarter results for the period ended September 30, 2007 on Monday. Revenues are expected to increase, reflecting the company's larger sales force. Furthermore, the breakdown of sales should also be monitored as the company is in the early stages of rolling out its product line. Revenue from the sale of PCT products and services was $136,355 for the three months ended June 30, compared to $28,783 a year earlier. This increase in revenue from PCT products and services was the result of the sale of four Barocycler NEP3229 PCT Sample Preparation Systems in the second quarter of 2007, versus one in the second quarter of 2006. Also contributing to this increase in revenue was an increase in the number of PULSE Tubes sold, revenue from Barocycler instruments under lease, and the recognition of extended service contract revenue. The company also recorded $65,772 of grant revenue during the second quarter of 2007. Top-line growth is expected on multiple fronts, including PCT products and services, and PULSE tubes. Commentary regarding the company's meetings with current distributors in France and Japan, and with potential distributors in Germany, Australia, and South Korea for its Barocycler NEP2320 should also be monitored as the product recently received CE Mark approval. Shares ended the week at $6.00, up 36 cents.

CEL-SCI Corporation (AMEX: CVM), developer of new immune system based treatments for cancer and infectious diseases, last week announced that its Board of Directors has approved a stockholder rights plan designed to ensure that all of its stockholders receive fair and equal treatment in the event of any proposal to acquire control of the company. The plan guards against partial or two-tier tender offers, coercive stock accumulation programs, and other tactics that may be used to gain control of CEL-SCI without offering a fair price to all stockholders. The company will issue rights to shareholders entitling the holder to purchase common stock at a substantial discount to the current market price in the event that any person or group acquires 15% or more of the company's stock. The distribution of the Series A and Series B Rights will be made on November 9, 2007 to stockholders of record on that date. Shares ended the week at $0.59, down two cents.

Digital Angel Corporation (AMEX: DOC), a technology company engaged in the development, manufacture, and marketing of visual and electronic identification tags and implantable RFID microchips, last week reported results from its third quarter ended September 30, 2007. The company reported record revenues of $20.3 million, a 64.0% increase, compared to revenue of $12.4 million in the third quarter of 2006. Net loss was $1.3 million, or ($0.03) loss per share, compared to a net loss of $1.4 million, or ($0.03) loss per share, a year earlier. Revenue was favorably impacted by $4.5 million sales from its newly-acquired McMurdo division, $2.6 million in sales of pet-implantable microchips to Schering-Plough, and a $1.5 million SARBE contract with the UK Ministry of Defence. The company also reported that it is in the final stages of its executive recruitment efforts, and expects to name a new CEO in December. Digital Angel also said that its merger with Applied Digital should be completed next month, in a move that is expected to simplify the capital structure and streamline expenses. Digital Angel stockholders will receive 1.4 shares of Applied Digital common stock for every share of Digital Angel common stock held. Shares ended the week at $1.13, down 19 cents.

Drug delivery company Generex Biotechnology Corporation, (NASDAQ: GNBT), last week announced that it has begun a Phase I clinical trial of its novel peptide vaccine for the treatment of prostate cancer. The 30-patient trial, a collaboration between Generex's Antigen Express division and the Saint Savas Cancer Hospital, is being conducted at the Laikon Hospital, University of Athens. The same vaccine peptide has recently entered Phase II clinical trials in breast cancer patients, having been shown to be safe, well-tolerated and able to generate a specific immune response in a Phase I trial. The company currently has an immunotherapeutic peptide in Phase I trials for the potentially pandemic H5N1 avian influenza. Shares ended the week at $1.60, down 5 cents.

Earnings Preview: Home Solutions of America, Inc. (Nasdaq: HSOA), a provider of restoration, construction and interior services to commercial and residential customers, is likely to release results from its third quarter ended September 30, 2007 on or about Wednesday, after taking a five-day extension. Shares have lost more than half of their value since the company released Q2 results, which raised fears that the company was experiencing liquidity issues. Likely overshadowing the quarterly results is the outcome of meetings the company began last week with FIGA, a state agency that pays claims that bankrupt insurance carriers are unable to satisfy. The company has claims of nearly $50 million from work completed several years ago, and the company said previously that a resolution of the undisputed amounts was likely to come by mid-November. A significant cash settlement could send shares dramatically higher, while continued uncertainty about when and whether HSOA will be paid would do little to alleviate fears of a liquidity crisis. We are cautiously optimistic that the company will receive a settlement next week. Q3 results could be impacted by constraints on working capital. Shares ended the week at $2.31, down 4 cents.

Tarrant Apparel Group (NASDAQ: TAGS), an innovative design and sourcing company for private label and private brand casual apparel, last week reported financial results for the three months and nine months ended September 30, 2007. The company reported revenue of $70.2 million in the third quarter of 2007, a 28% increase compared to $54.6 million in the same period in 2006. Private Brands sales were $12.0 million in the 2007 quarter, a 41% increase over last year, with the increase coming mainly from an increase in sales of American Rag CIE brand to Macy's Merchandising Group in the third quarter of 2007. Private Label sales increased 26% in the 2007 quarter to $58.2 million from $46.1 million reported in 2006. Net income after tax for the 2007 third quarter was $1.6 million or $ 0.05 a share, compared to a loss of $25.4 million ($0.83) per share for the 2006 third quarter. For the nine months, Tarrant Apparel had net sales of $186.4 million compared to $175.0 million in the same period in fiscal 2006. The company reported net income of $1.4 million, or $0.05 per share, in the first nine months of 2007, compared to a net loss of $23.9 million ($0.78) per share in the first nine months of 2006. Tarrant Apparel reiterated its revenue guidance of $230-240 million for the full fiscal year. Shares ended the week at $1.15, up two cents.

Telkonet, Inc. (AMEX: TKO), the leader in providing in-building broadband access over existing electrical wiring and innovative energy management systems, last week reported it has sold its interest in BPL Global, Ltd., a privately-held company, to certain existing stockholders of BPL Global for $2.0 million, payable in cash. This represents a profit of approximately $1.85 million since Telkonet's investment in BPL Global in early 2005. The company also reported sharply improved 2007 Q3 results, as revenue surged to $4.7 million, up more than four-fold from a year-earlier. Gross profit jumped to $1.2 million, from less than $100,000 in the year-earlier period. Shares ended the week at $1.53, down 4 cents.[/B]

Earnings Preview: USA Technologies, Inc. (NASDAQ: USAT), a developer of cashless vending and energy management products, is expected to announce earnings on Monday. As the company continues to gain traction in targeted markets, a continuation of impressive revenue growth and a reduced per share loss should be anticipated. The status of the launch of the company's new Quick Start purchasing program giving vending machine operators and bottler a no money down option should be watched as well, as should commentary regarding the company's relationships with Bed Bath & Beyond and MasterCard Worldwide. Also of importance would be comments regarding the company's EnergyMiser Turnkey Program as oil prices near $100 per barrel. Additionally, last week USAT announced that it has been issued a patent for the VM2iQ, the second generation of the VendingMiser which is installed internally, operates on audio signals, and switches the cooling system in and out of energy savings mode by monitoring vending machine sales. The VM2iQ technology is designed to save vending machine operators up to 35 percent annually in utility costs, and has already been installed in approximately 30,000 vending machines nationwide. The U.S. Patents and Trademark Office has issued patent number 7,286,907 for Method and Apparatus for Conserving Power Consumed by a Refrigerated Appliance Utilizing Audio Signal Detection. USA Technologies has now received 12 patents relating to its EnergyMiser energy management technologies, and a total of 69 patents overall. Shares ended the week at $6.56, down 72 cents.

Earnings Preview: Multiband Corporation (NASDAQ: MBND), a leading provider of video, data, and voice systems and services to multiple dwelling units (MDUs), is expected to release third quarter earnings for the period ended September 30, 2007 on Monday. The Q3results are likely to be overshadowed by additional details the company provides surrounding the merger with DirecTECH, which is supposed to dramatically change the size and profitability of the combined company. MBND investors are likely to own 21-24% of the new company. The transaction is expected to close early next year. Shares ended the week at $3.05, up 25 cents.

Advanced Cell Technology, Inc. (OTCBB: ACTC), a company applying stem cell technology in the emerging field of regenerative medicine, and the Casey Eye Institute at Oregon Health & Science University, last week reported results from a year-long study of the company's GMP-compliant RPE cells in the RCS Rat, a well validated animal model of retinal disease. The results of the study showed that the RPE cells demonstrated a statistically significant therapeutic effect, and researchers concluded that that visual function can be rescued and preserved in this animal model of disease utilizing GMP-compliant human ES-derived RPE cells, and that these cells may provide an effective donor cell source to rescue photoreceptors in conditions like age-related macular degeneration, where RPE function is compromised. The company plans to present this data to the FDA when it files an IND for the RPE therapy. Additionally, Advanced Cell reported that a controlled, randomized clinical trial using ACT's myoblast therapy demonstrated marked improvement in heart failure symptoms after both six and twelve months, demonstrating that the effects of ACT's myoblast therapy persist for an extended period of time, and also showed evidence that the hearts of the patients that received the therapy showed less cardiac remodeling than did control patients. This is the first U.S. trial using catheter-delivered muscle stem cells to treat congestive heart failure, suggesting that ACT's technology could give doctors the opportunity to successfully replace scarred heart tissue with healthy muscle via intracardiac injections of autologous skeletal myoblasts. The company plans to begin enrollment of a Phase II trial in the next few months. Shares ended the week at $0.26, down one penny.

Access Pharmaceuticals, Inc. (OTCBB: ACCP), an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients, last week announced it had executed arrangements for a $19.5 million recapitalization. The company agreed to sell an aggregate of $9.5 million in gross proceeds of the company's newly issued Series A Convertible Preferred Stock to a group of investors including SCO Capital Partners and Perceptive Life Sciences. Additionally, SCO Capital Partners, Oracle Partners and certain of their affiliates have agreed to exchange $10 million principal amount of senior debt into Series A Convertible Preferred Stock. Access also issued approximately 3.2 million warrants, exercisable at $3.50 per share. In addition to providing capital to fund its ongoing Phase II trial of ProLindac, the company's lead anti-cancer platinum drug, the transaction helps simplify the company's balance sheet. Shares ended the week at $3.11, up one cent.

Earnings Preview: ProLink Holdings Corp., (OTCBB: PLKH), the world's largest provider of Global Positioning System golf course management systems and on-course advertising, will report third quarter results for the period ended September 30, 2007 on Wednesday after the market closes. Investors should be looking for a strong sequential increase in advertising revenue and updates pertaining to its major advertising distribution deal with ABC National Television Sales. ABC's extensive relationships and sales force should substantially increase PLKH's reach and provide improved operating and cash flow performance, as well as new clients. The company should also discuss the timing of the Elumina acquisition, which is expected to be accretive and close later this month. The company reported disappointing second quarter results, but indicated that it expected its business to rebound in the third quarter and second-half of the year. Additionally, ProLink announced last week that the Cypress Course at The Grand Club in Palm Coast, FL, and the Tuscan Ridge Golf Course in Paradise, CA now feature the ProLink Solutions GPS system. Both courses plan to participate in ProLink's exclusive national advertising program. Shares ended the week at $0.73, down 12 cents.

Seaway Valley Capital Corporation (OTCBB: SWVC) said last week that its wholly owned subsidiary, WiseBuys Stores, Inc., completed its acquisition of Patrick Hackett Hardware Company. Hacketts, one of the nation's oldest retailers with roots dating back to 1830, is a full line department store specializing in name brand merchandise and full service hardware. Hacketts, now with nine locations in New York, features brand name clothing for men, women, and children, and a large selection of athletic, casual, and work footwear. WiseBuys Stores, Inc. was formed and began operations in 2003 as a direct result of the closing of small-town retailer, Ames Department Stores. WiseBuys initially focused its efforts on serving the discount retail needs of rural communities throughout northern and central New York. Shares ended the week at $0.022, unchanged.

Collexis Holdings, Inc. (OTCBB: CLXS), a global knowledge discovery company, last week reported that Mediator, a web-based research tool powered by SyynX Solutions, a wholly owned subsidiary of Collexis Holdings, Inc., has been selected by the North Carolina Bar Association as its research platform. Currently in use by global health organizations such as Johns Hopkins, the Mayo Clinic, Harvard University's Dana Farber Cancer Institute and The National Institutes of Health, the Mediator platform has been expanded to provide legal professionals with the ability to identify, quantify and qualify expert witnesses in all areas of biomedical and healthcare litigation. This selection highlights the potential of the use of Collexis' Fingerprint technology in helping researchers in any capacity, in any field. Shares ended the week at $1.25, down 20 cents.

MSTI Holdings, Inc. (OTCBB: MSHI), a carrier class communications technology company, last week reported it has completed the first phase of the deployment of its Internet Protocol Television (IPTV) service in the New York City area through the installation of Earth Stations (MST Antenna Farm), which will access more than 15 satellites, and gives the company the ability to provide more than 500 HDTV channels. The IPTV service provides bundled services such as television, Internet, and telephone service over the NuVisions' gigabit network that connects the properties it serves in a redundant gigabit ring, a virtual fiber optic network in the air within New York City. The company also plans to add more channels and features, such as video-on-demand, movies, games and interactive content, to the service when fully deployed. According to estimates, worldwide IPTV service revenue is expected to top $44 billion by 2009, with subscribers in North America alone expected to increase by over 12,000%. Shares ended the week at $1.01, down 4 cents.

Smart Energy Solutions, Inc. (OTCBB: SMGY), developer and manufacturer of the innovative Battery Brain product line of vehicle and marine devices, last week announced it has signed a major distribution agreement with Lund Industries. Lund Industries has been known as a leader in the design, manufacturing, installation and distribution of public safety vehicular equipment to federal, state and local agencies for over 25 years. This agreement will provide considerable exposure for Smart Energy's Battery Brain to these agencies, as well as to other potential utility and commercial customers. Lund has reportedly already secured a significant size order for a national government contract of the Battery Brain Bronze model. Shares ended the week at $0.42, unchanged.

VoIP, Inc. (OTCBB: VOIC), a provider of turnkey Voice over Internet Protocol (VOIP) communications solutions for service providers, last week reported that the company generated revenue of approximately $840,000 in the month ended October 30, 2007, an increase of 12.4% compared to the previous month. In addition, VoIP also improved its variable gross margin from 32% in September to 36% in October. The company expects that these monthly increases will continue, and reiterated it expects to be cash-flow positive for the month of November. Shares ended the week at $0.24, down 9 cents.

On the Wires: Pluristem Life Systems, Inc. (OTCBB: PLRS), a bio-therapeutics company dedicated to the commercialization of products for a variety of malignant, degenerative and auto-immune indications, reported that it intends to effect a 1 for 200 reverse stock split in conjunction with an application to list its shares on the NASDAQ Capital Market. The listing is part of the company's strategy to strengthen its financial position, broadening the availability of its stock to both institutional and individual investors.

SPECIAL SITUATION:

Deer Valley Corporation, Inc. (OTCBB: DVLY) $0.99

The slump in the housing market, combined with the current crisis in the credit markets, has many investors completely ignoring the homebuilding industry. Numerous media headlines have reported financial losses and even bankruptcies among homebuilders. We have found an exceptional company that is bucking the trend! In the little over three years since its inception early 2004, Deer Valley Corporation, Inc. has grown from a start up to a profitable, multi-plant operation with a current run rate of over $65 million per year.

Deer Valley is a provider of high end, feature rich HUD Code and modular homes. The corporate headquarters is located in Tampa, FL, and the company's two manufacturing plants are located in northwestern Alabama. Through its subsidiary, Deer Valley Homebuilders, Inc., the company is engaged in the production, sale, and marketing of factory-built homes to homebuyers located in the southeastern and south central United States. With over 100 authorized dealer locations in 13 states, Deer Valley has built a strong reputation in the region hardest hit by the hurricanes of 2005. The company is young, but its management team has over 250 years of industry experience. The company recorded first year (2004) sales of $16 million; 2005 sales of $35 million; and 2006 sales of over $65 million. Sales for the year 2007 will be comparable to 2006 with continuing strong earnings.

Deer Valley's rapid growth under challenging industry conditions has primarily resulted from a combination of two elements. The first is a unique corporate culture which stresses strong relationship with the company's employees, vendors, dealers and homebuyers. The second element is the unusual strength of its heavy-built home product line. The term heavy-built refers to the company's policy of providing homes with 2x6 exterior walls, closely spaced 2x8 floor joists, and custom steel frames fabricated in-house. In addition, the company's products have set a new standard for aesthetic appeal in the manufactured housing market by providing 100% finished dry drywall construction, eight to nine foot ceiling heights and enhancements like oak cabinets, masonry fireplaces, hand-laid tile flooring, high-grade appliances and luxurious master suites. All of this is provided at prices that are more affordable than similarly equipped site-built homes.

Deer Valley introduced its new line of modular homes at a trade show in Tunica, Miss in March 2007. The wisdom of this move into modular was confirmed when in June, Deer Valley announced that it had been selected by the State of Mississippi to produce 50 two bedroom and 100 three bedroom cottages as part of a program designed to test and evaluate future disaster housing units. These cottages are unique in that they are designed, built, and certified to meet both federal HUD-Code and Modular home standards. The initial contract award was for $7,535,000. The company completed the entire contract within the third quarter, ahead of contractual requirements, without a major disruption of the company's standard product flow. In October 2007, the company received a $7,185,000 contract extension for an additional 150 two-bedroom cottages. The company expects its record of success on this project to generate exposure to other states' emergency management programs.

Evidence is mounting that the modular segment of the factory built housing market will drive much of the overall housing industry's future growth. The difference between HUD Code homes and modular homes is primarily one of architectural freedom; HUD code homes being basically a simple rectangle, while modular homes can be designed to conform to any shape or floor plan suitable for site built homes. The company's extensive knowledge of the techniques necessary to produce finished drywall products in a production environment made this a natural course of expansion, and the move is clearly paying off.

The company recently reported a 14.5% increase in revenue in the third quarter of 2007 as compared to the second quarter, with the third quarter having the second-highest reported revenue in the company's history. While the industry is currently out of favor, it was just two years ago that investment guru Warren Buffet, a renowned value investor, invested over $1 billion in Clayton Homes, Inc., a larger peer of Deer Valley.

Deer Valley was created and has thrived during a severely challenging market cycle. Any turnaround in the housing industry can be expected to be a greater benefit to this company than many of its competitors in the region it serves. Furthermore, this company is well managed, well capitalized and profitable. It is fully prepared to accelerate its growth through acquisition as well as through expansion of its product line and geographic sales footprint. The company is currently below the radar for many investors because it is traded on the NASD Bulletin Board, but may not be for long if it continues to report strong results.

A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO ITS OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. This publication accepts compensation from companies that it features. This newsletter should not be regarded as an independent publication. Our editors may, from time to time, acquire positions in the companies that they cover. This could represent a conflict of interest. The CEOcast newsletter shall be under no obligation to inform readers about its trading activities. CEOcast's editors reserve the right to buy or sell shares in these companies at any time. The following companies, featured in this newsletter, have compensated CEOcast: Access Pharmaceuticals, seven thousand five hundred dollars per month and eight thousand seven hundred twenty shares of stock for a six-month program, Advanced Cell Technologies, fifteen thousand dollars per month, Collexis Holdings, twenty thousand dollars per month, CEL SCI Corporation, five thousand dollars and two hundred thousand shares of stock for a one-year program, Digital Angel Corporation, twelve thousand five hundred dollars per month, Generex Biotechnology, five thousand dollars per month and two hundred twenty five thousand shares of stock for a one-year program; CEOcast received five hundred twenty thousand shares from previous agreements, Home Solutions of America, editors of CEOcast have purchased approximately one million nine hundred thousand shares, Hythiam, ten thousand dollars per month and sixteen thousand five hundred shares of stock for a one-year program; CEOcast received sixty-six thousand shares from previous agreements; editors of CEOcast have also purchased approximately one million four hundred twenty-five thousand shares of the company's stock, IceWEB, Inc., ten thousand dollars per month and two hundred thousand shares of stock for a six month program, Multiband Corporation, ten thousand dollars per month and eighty thousand shares of stock for a six month program, MSTI Holdings, ten thousand dollars per month and two hundred fifty thousand shares of stock for a one-year agreement, Pressure Biosciences, twelve thousand five hundred dollars per month, ProLink, seven thousand five hundred dollars per month and one hundred eighty five thousand shares of stock for a one year program, Pluristem Life Systems, ten thousand dollars per month and one million shares of stock for a six-month program, Smart Energy Solutions, fifteen thousand dollars per month for a six-month program, payable half in cash, Tarrant Apparel, seven thousand five hundred dollars per month and sixty thousand shares of stock for a one-year agreement, Telkonet, ten thousand dollars per month and one hundred thousand shares of stock for a one-year program, USA Technologies, ten thousand dollars per month, VoIP, Inc. ten thousand dollars per month and three hundred fifty thousand shares of stock for a one-year program, Seaway Valley Capital, five thousand dollars per month and ten million shares of stock for a one-year agreement, Deer Valley Corporation, fifteen thousand dollars per month.